Differences between blood-pressure-lowering drugs

This publication has 7 references indexed in Scilit:

• Major Cardiovascular Events in Hypertensive Patients Randomized to Doxazosin vs Chlorthalidone: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
  JAMA, 2000
• Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients
  New England Journal of Medicine, 2000
• Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study
  The Lancet, 1999
• Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial
  The Lancet, 1999
• Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension
  The Lancet, 1997
• Prevention of Heart Failure by Antihypertensive Drug Treatment in Older Persons With Isolated Systolic Hypertension
  JAMA, 1997
• Blood pressure, antihypertensive drug treatment and the risks of stroke and of coronary heart disease
  British Medical Bulletin, 1994